NEW YORK (GenomeWeb) – BGI Dx, a subsidiary of BGI, and Italian firm Bioscience Genomics today announced they have signed a five-year framework agreement focused on non-invasive prenatal testing.

The agreement defines terms for the collaboration between the parties, as well as activities and exchanges, and specifically facilitates a technology transfer process for Bioscience Genomics' use of BGI's genetic sequencing technology platforms in the NIPT space.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.